Citadel Advisors’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.08M | Buy |
|
|||||
|
2025
Q1 | $1.19M | Sell |
|
|||||
|
2024
Q4 | $6.87M | Buy |
|
|||||
|
2024
Q3 | $5.49M | Buy |
|
|||||
|
2024
Q2 | $581K | Sell |
|
|||||
|
2024
Q1 | $13.3M | Sell |
|
|||||
|
2023
Q4 | $19.3M | Buy |
|
|||||
|
2023
Q3 | $1.57M | Buy |
|
|||||
|
2023
Q2 | $2.04M | Buy |
|
|||||
|
2023
Q1 | $2.09M | Sell |
|
|||||
|
2022
Q4 | $35.1M | Sell |
|
|||||
|
2022
Q3 | $27.9M | Buy |
|
|||||
|
2022
Q2 | $10.8M | Sell |
|
|||||
|
2022
Q1 | $17.4M | Sell |
|
|||||
|
2021
Q4 | $18.6M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $44K | Buy |
|
|||||
|
2020
Q4 | $330K | Buy |
|
|||||
|
2020
Q3 | $128K | Buy |
|
|||||
|
2020
Q2 | $17K | Sell |
|
|||||
|
2020
Q1 | $10K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $57K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $55K | Buy |
|
|||||
|
2018
Q3 | $57K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $117K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $5K | Sell |
|
|||||
|
2016
Q2 | $15K | Sell |
|
|||||
|
2016
Q1 | $29K | Buy |
|
|||||
|
2015
Q4 | $21K | Buy |
|